Juhász Attila, Katona Evelin, Csongrádi Eva, Paragh György
Debreceni Egyetem, Orvos- es Egészségtudományi Centrum, Belgyógyászati Intézet l. sz. Belklinika, Anyagcsere Tanszék.
Orv Hetil. 2006 Apr 2;147(13):579-90.
Overweight and obesity are worldwide problems, its health and psychosocial burden on the individual and on society are tremendous. Diagnosing obesity is rather easy, and is based on simple anthropometric measurements, such as body weight, height and waist circumference. The different classes of obesity are determined by body mass index, which, together with waist circumference and comorbid conditions and other risk factors determine the individual risk for mortality and morbidity. Obesity is due to genetic and environmental factors, mainly is the consequence of excess calorie intake and sedentary lifestyle. The fat mass of the body is under neuroendocrine control, the central controller is the hypothalamus. Leptin, produced by adipocytes in proportion to fat mass, is the afferent signal to the hypothalamus. Decreasing or increasing levels of leptin result in orexigen and anorexigen neurotransmission, which mediate efferent activation towards food consumption and energy storage, or towards food restriction and energy expenditure, respectively. The balance of these events and/or the ,set point" of the controller--if leptin resistance is present--is shifted towards higher body/fat mass in obesity. Management of obesity is complex, however, in all stages of obesity lifestyle changes are mandatory--including diet, exercise and behavior modification. Pharmacotherapy might be needed if lifestyle changes alone do not result an acceptable weight loss. For the long-term treatment of obesity sibutramin and orlistat are the available approved drugs. In case of morbid obesity (body mass index > 40 kg/m2, or > 35 kg/m2 plus comorbid conditions and other risk factors) surgery might be the treatment of choice. There are different surgical methods, among those a widely used method nowadays is the laparoscopic adjustable gastric banding procedure.
超重和肥胖是全球性问题,其对个人和社会造成的健康及心理社会负担极为巨大。诊断肥胖相当容易,基于简单的人体测量指标,如体重、身高和腰围。肥胖的不同类别由体重指数决定,体重指数连同腰围、合并症及其他风险因素共同决定个体的死亡和发病风险。肥胖是由遗传和环境因素导致的,主要是热量摄入过多和久坐不动生活方式的结果。人体脂肪量受神经内分泌控制,中枢控制器是下丘脑。脂肪细胞按脂肪量比例产生的瘦素是传递至下丘脑的传入信号。瘦素水平降低或升高分别导致促食欲和抑食欲神经传递,进而分别介导对食物摄入和能量储存的传出激活,或对食物限制和能量消耗的传出激活。在肥胖状态下,如果存在瘦素抵抗,这些事件的平衡和/或控制器的“设定点”会朝着更高的体重/脂肪量偏移。肥胖的管理很复杂,然而在肥胖的各个阶段,生活方式改变都是必不可少的,包括饮食、运动和行为改变。如果仅靠生活方式改变不能实现可接受的体重减轻,可能就需要药物治疗。对于肥胖的长期治疗,西布曲明和奥利司他是已获批的可用药物。对于病态肥胖(体重指数>40kg/m²,或>35kg/m²且伴有合并症及其他风险因素),手术可能是首选治疗方法。有不同的手术方式,其中现今广泛使用的一种方法是腹腔镜可调节胃束带术。